Xiaosong Li

Dr. Xiaosong Li


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
YLYong Li
Yong Li
XLXiaosong Li
Xiaosong Li
ADAustin Doughty
Austin Doughty
CWConnor West
Connor West
LWLu Wang
Lu Wang
WCWei Chen
Wei Chen

31 May 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
JLJiangbo Li
Jiangbo Li
ZSZhijia Sun
Zhijia Sun
YCYingshu Cui
Yingshu Cui
LQLingmei Qin
Lingmei Qin
FWFengyun Wu
Fengyun Wu
XLXiaosong Li
Xiaosong Li
Background: Lung cancer has considerably high mortality and morbidity rate. Lung adenocarcinoma (LUAD) tissues highly express lamin B1 (LMNB1), compared with normal tissues. In this study, we knocked down LMNB1 in LUAD cells A549 and NCI-1299 to explore the effect of its inhibition on the proliferation of cells and the potential mechanism.Methods: Using bioinformatics methods, we analyzed the specificity of LMNB1 mRNA expression level in LUAD and its effect on prognosis from TCGA data. SiRNAs were used to knock down LMNB1 in the A549 cell line, and the knockdown effect was identified by western blotting and qRT-PCR. Through CCK8 cell proliferation assay, wound healing assay, TRAP, cloning formation Assay, DNase I-TUNEL assay, ATAC-seq, immunofluorescence, FISH, in vivo mouse xenograft studies, etc, we evaluated the influence and mechanism of LMNB1 on LUAD cell line proliferation in vitro and in vivo.Results: According to bioinformatics analysis, LMNB1 is substantially abundant in LUAD tissues and is associated with tumor stage and patient survival (P < 0.05). After silencing LMNB1, the rate of cell growth, wound healing, the number of transwells, and the number of cell colonies all decreased significantly (P < 0.01). With the decreased LMNB1 expression, H3K9me3 protein expression decreases, chromosome accessibility increases, P53, P21, P16 and γ-H2AX protein expression increases, and the number of senescence staining positive cells increases. At the same time, in vivo mouse xenograft experiments showed that the tumor volume of the LMNB1-silenced group was significantly reduced, compared to that of the control group (P < 0.01), and the proliferation biomarker Ki-67 level (P < 0.01) was considerably reduced.Conclusions: Overexpression of LMNB1 in LUAD cells is significant, which has excellent potential to be an indicator for evaluating the clinical prognosis of LUAD patients and a target for precise treatment.

20 February 2019 in Oncology Letters
Verified
Journal Article
Closed access
PDF file
SLShan Long
Shan Long
YXYuanyuan Xu
Yuanyuan Xu
FZFeifan Zhou
Feifan Zhou
BWBo Wang
Bo Wang
YYYunning Yang
Yunning Yang
XLXiaosong Li
Xiaosong Li
Photothermal therapy, a type of laser application, has the ability to eradicate tumor cells by a local thermal effect and elicit a tumor specific immune response. Indocyanine green (ICG), a photosensitizer, can effectively elevate the local temperature by absorbing energy from the laser. The present study aimed to investigate the characteristics of temperature changes during photothermal therapy with an infrared thermometer in an ICG solution and in tumor‑bearing mice treated with a combination of laser and ICG. Additionally, the present study observed the morphological changes of tumor tissue by hematoxylin‑eosin staining following photothermal therapy. In the solution experiment, when the laser power density was 1 W/cm2 and the concentration of ICG was 0 or 0.0187 mg/ml, the temperature of the water was elevated by 3 and 28˚C, respectively. In the tumor‑bearing mice experiment, when the laser power density was 1 W/cm2 and the concentration of ICG was 0 and 0.1 mg/ml, the temperature of the tumor‑bearing mice was elevated by 6.9 and 28.5˚C, respectively. With an increase in laser power density, including 0.6, 0.8 and 1.0 W/cm2, the temperature was 23.3, 26.7 and 28.5˚C, respectively. Pathological tissue sections demonstrated that a large number of tumor cells experienced necrosis, and the envelope of the tumor was destroyed. Numerous inflammatory cells, in particular lymphocytes, infiltrated into the tumor tissue following tumor tissue treatment with a combination of laser and ICG. These results indicated that a combination treatment with laser and ICG may significantly increase the temperature of the water solutions and in the tumor‑bearing mice. The concentration of ICG and laser power density contributed to the temperature elevation, in particular to the concentration of ICG.

1 January 2020 in Therapeutic Advances in Respiratory Disease
Verified
Journal Article
Open access
PDF file
JHJia Hu
Jia Hu
BZBaoshi Zhang
Baoshi Zhang
FYFangfang Yao
Fangfang Yao
YFYan Fu
Yan Fu
DCDianjun Chen
Dianjun Chen
XLXiaosong Li
Xiaosong Li
EML4-ALK rearranged malignant pleural mesothelioma (MPM) is rare and its responses to anaplastic lymphoma kinase (ALK) inhibitors, including alectinib and lorlatinib, remain unexplored. In this case report, we describe a patient with EML4-ALK-rearranged stage IIIB MPM who was administered with alectinib and lorlatinib as first-line and fourth-line therapy, respectively. He had remarkable response evaluated as partial response on both regimens lasting approximately 3.5 months on each regimen. His plasma samples were collected during the treatment course and submitted for targeted sequencing to understand the molecular mechanisms of his therapeutic resistance. Sequencing analysis revealed the emergence of ALK I1171N and L1196M at alectinib progression. Meanwhile, ALK I1171N, L1196M, and G1202R mutations were identified at lorlatinib progression, wherein L1196M is confirmed to be in cis to G1202R. We speculate that these multiple mutations synergistically mediated his resistance to both alectinib and lorlatinib. Our report describes the detection of EML4-ALK rearrangement in a patient with MPM who had remarkable therapeutic response with ALK inhibitors. Moreover, our case also revealed acquired mechanisms of lorlatinib resistance mediated by multiple mutations ALK I1171N, L1196M, and G1202R, contributing an incremental step to our understanding of the complexity of acquired resistance mechanisms in sequential ALK inhibitor therapy. The reviews of this paper are available via the supplemental material section.

15 September 2021 in Nanophotonics
Verified
Journal Article
Open access
PDF file
SLShanshan Liu
Shanshan Liu
RSRuixiang Song
Ruixiang Song
XLXiaosong Li
Xiaosong Li
FZFeifan Zhou
Feifan Zhou
Treatment of malignant tumors has always been a worldwide challenge. The complexity, diversity, and heterogeneity of tumors have prompted the treatment strategies to gradually shift from monotherapy to combination therapy that can synergize multiple treatment modalities. With unique physical and chemical properties, nanomaterials have been widely used in different cancer therapies, including chemotherapy, immunotherapy, and phototherapy. Especially, the variability and integrity of nanomaterials make them ideal media for synergistic collaboration strategies. Here, we provide our perspective on the synergistic strategy of nanoplatform‐mediated phototherapies and related combination therapies, specifically photochemotherapy, photoradiotherapy, and photoimmunotherapy. Besides, we provide an analysis and outlook on the current challenges faced by synergistic nanophototherapy.

1 January 2021 in Cancer Control
Verified
Journal Article
Open access
PDF file
YBYiliang Bi
Yiliang Bi
MMMin Min
Min Min
YCYinshu Cui
Yinshu Cui
YXYuanyuan Xu
Yuanyuan Xu
XLXiaosong Li
Xiaosong Li
Early diagnosis and early treatment of gastrointestinal tumors are helpful to improve the prognosis of patients. Endoscopy is the best method for the diagnosis of early gastrointestinal tumors, but some early flat tumors may be missed under conventional white-light endoscopy. In order to improve the accuracy of endoscopic diagnosis of gastrointestinal tumors, especially early flat tumors, endoscopic autofluorescence imaging (AFI) as a new technique has been widely used in clinics in recent years. This article reviews the progress of the clinical application of AFI in the diagnosis of various gastrointestinal tumors.